You searched for Antibody candidate - Page 34 of 69

Best in Biotech 11 Jul 2024

From data to discovery: Five bioinformatics companies you should know in 2024

…neuron disease that affects the nerve cells in the spinal cord and brain. The drug candidate VRG50635 is a small molecule PIKfyve inhibitor that was entirely discovered and developed using…

July 11, 2024 - 7 minutesmins - By Roohi Mariam Peter

Startup Scout 21 Nov 2022

Osivax is designing future-proof influenza and Covid vaccines

…T cells must often be tested in tissue samples. “If you can get an antibody-based vaccine that protects well and neutralizes the virus, you wouldn’t need to care that much…

November 21, 2022 - 5 minutesmins - By Jonathan Smith

In Depth 27 Mar 2024

Are new treatments for multiple sclerosis on the horizon?

…for different forms of multiple sclerosis. Vidofludimus calcium: a potential treatment for multiple sclerosis Mechanism of action of vidofludimus calcium Immunic Therapeutics’ vidofludimus calcium is a drug candidate being tested…

March 27, 2024 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 20 Mar 2017

French Biotech fails Second Phase II Trial for Cardiovascular Disease

Cerenis therapeutic’s lead candidate CER-001 has failed Phase II for the treatment of patients with post-acute coronary syndrome (ACS). The French-based Biotech Cerenis is developing therapies for the treatment of…

March 20, 2017 - 3 minutesmins - By Melanie De Almeida

Best in Biotech 4 Apr 2023

6 biotechs that have stepped into the protein degradation space

…even orally. Arvinas’ PROTAC-based pipeline consists of more than 12 drug candidates, which are being studied in immuno-oncological and neuroscience research. Its lead candidate, ARV-471, is an investigative oral protein…

April 4, 2023 - 7 minutesmins - By Roohi Mariam Peter

Best in Biotech 4 Nov 2022

Get to know 15 of the best biotech companies in Paris

…to modulate the body’s immune system through its immune enhancing and antiviral platforms to treat chronic inflammatory diseases, viral infections and cancer. The company’s lead candidate entered phase 3 trials…

November 4, 2022 - 11 minutesmins - By Omnia Ibrahim

News and Trends 11 Jan 2022

Sanofi Joins AI Gold Rush in €4.6B Drug Discovery Pact with Exscientia

…discovery of disease targets and the design of small molecule candidates, and Sanofi will take over from preclinical development onwards. Exscientia expects to receive €88M ($100M) upfront in addition to…

January 11, 2022 - 4 minutesmins - By Jonathan Smith

Expert Advice 1 Mar 2024

Tips on how to write a compelling biotech resume

As hundreds of resumes make their way to a recruiter’s office, only a handful of the candidates get past an interview. Although acing interviews and networking can boost your chances…

March 1, 2024 - 10 minutesmins - By Roohi Mariam Peter

In Depth 12 Oct 2023

Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated?

…melanoma, glioblastoma multiforme, castrate-resistant prostate cancer and gastrointestinal stromal tumor. The candidate is designed to target a particular metabolic pathway in the mitochondria. The candidate is presently in phase 1B…

October 12, 2023 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 3 Apr 2017

Massive €800M Acquisition of Belgian Biotech treating Menopause

…candidate targets the tachykinin receptor NK3 in neurons located in the brain. This advantage will certainly give the candidate a strong entrance in the menopausal hot flashes market, which is…

April 3, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 14 May 2018

German Biotech Expands Oncology Deal with Bluebird bio to $1.5Bn

…to cover two additional TCR candidates. The potential value of the deal thus goes up from $1Bn to $1.5Bn — plus royalties on sales if the candidates make it to…

May 14, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 2 Apr 2020

iTeos Therapeutics’ Cancer Immunotherapy Boosted with €114M Funding

…iTeos, explained to me that both of its immunotherapy candidates target key resistance mechanisms that tumors develop against anti-cancer drugs known as immune checkpoint inhibitors. iTeos’ lead candidate drug does…

April 2, 2020 - 3 minutesmins - By Laura Cowen

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

From data to discovery: Five bioinformatics companies you should know in 2024

Osivax is designing future-proof influenza and Covid vaccines

Are new treatments for multiple sclerosis on the horizon?

French Biotech fails Second Phase II Trial for Cardiovascular Disease

6 biotechs that have stepped into the protein degradation space

Get to know 15 of the best biotech companies in Paris

Sanofi Joins AI Gold Rush in €4.6B Drug Discovery Pact with Exscientia

Tips on how to write a compelling biotech resume

Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated?

Massive €800M Acquisition of Belgian Biotech treating Menopause

German Biotech Expands Oncology Deal with Bluebird bio to $1.5Bn

iTeos Therapeutics’ Cancer Immunotherapy Boosted with €114M Funding

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!